Recent BioUtah News & Events

For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.

Renalytix reported financial results for the quarter ended September 30, 2021.

The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery

Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.

Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).

Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.

Collaboration Expands Clinical Sites for Trial

In two separate rulings on Tuesday, federal judges temporarily halted the Biden Administration’s COVID-19 vaccine mandates for healthcare workers and federal contractors. One ruling, in a Missouri federal district court, prohibits CMS from enforcing its COVID-19 vaccine mandate in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. A second […]

NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS

Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry

IONIQ Sciences Proudly Announces that Mrs. Jan Poulsen is a Lung Cancer Hero

None of the mutations in the Omicron variant interfere with any of the Company’s COVID-19 PCR diagnostic assays

The CAO Group, Inc. has launched the world’s first in-office and take-home teeth whitening strip system for dental practices, SheerWhite® In-Office Teeth Whitening Strips and SheerWhite® Take Home Teeth Whitening Strips.

IONIQ Sciences Announces MedTech Breakthrough Award for “Oncology Innovation of the Year 2021”

Bluewind Medical announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be the basis by which the company will seek US-FDA (Food & Drug Administration) marketing clearance in the United States. OASIS is a 150-patient prospective clinical study designed to demonstrate the safety and efficacy of Bluewind Medical’s RENOVA […]

BioUtah and BioHive on Nov. 12 presented with great fanfare the Renalytix BioHive Summit – the 12th annual gathering of Utah’s life sciences community – but this year with a new name. Convening under the BioHive banner is part of a larger effort to brand, build and bring together Utah’s fast-growing life sciences hub. We […]

Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) on Tuesday, November 16, introduced the CURES 2.0 bill, a sequel to the initial 21st Century Cures Act that passed Congress in 2015. According to a statement released by DeGette, while the first CURES bill sought to improve how new drugs and treatments are researched and developed in […]

Statement from Senator Orrin G. Hatch: Drug Pricing Provisions in Infrastructure Bill Could Undermine Hatch-Waxman

Introducing a New Approach to Diagnose and Treat Cancer.  NuView Life Sciences, Inc established NuView LATAM in Mexico City. 

nView announces the 510(k) clearance of the nView s1 with navigation option by the FDA along with AI-enabled image analysis and 3D stitching

Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in the Phase 1 dose expansion portion of the study evaluating the investigational agent TP-1287, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, in patients with sarcoma. “Patients with sarcoma currently face a significant […]

The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.

AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.